Aniara Diagnostica is pleased to announce the availability of Chromogenic Substrates for use in Thrombin and Factor Xa assays for quality control (QC testing)
WEST CHESTER, Ohio, May 6, 2022 /PRNewswire-PRWeb/ -- Aniara Diagnostica, a multi-national distributor of diagnostic and research agents, as well as screening tools, has strengthened its commitment to meeting today's highest standards for product quality and cost-efficient delivery.
For Research Use Only. Not for Use in Diagnostic Procedures.
Aniara Diagnostica has various chromogenic substrates available for Quality Control (QC testing)
A229011 FXa CHROMOGENIC SUBSTRATE (HYPHEN BioMed CS-11(32)) Click here for more information
A229001 THROMBIN CHROMOGENIC SUBSTRATES (HYPHEN BioMed CS-01(38)) click here for more information
A229014 FXa CHROMOGENIC SUBSTRATE (HYPHEN BioMed CS-11(65)) click here for more information
A229021 ACTIVATED PROTEIN C (aPC) CHROMOGENIC SUBSTRATE (HYPHEN BioMed CS-21(66)) click here for more information
A229041 PLASMIN/PLASMINOGEN-SK CHROMOGENIC SUBSTRATE (HYPHEN BioMed CS-41(03)) click here for more information
Click the link to see a competitor comparison
Literature (aniara.com)
The entire Aniara product line is available for purchase at http://www.aniara.com. The Company distributes products in North America, Central America, South America, Sweden, Norway, Denmark, Finland, Lithuania, Latvia, Estonia and Iceland.
Media Contact
Maria Waldron, Aniara Diagnsotica, 5133423018, [email protected]
SOURCE Aniara Diagnsotica
Share this article